Overview

Behavioral Effects of Kuvan in Children With Mild Phenylketonuria

Status:
Terminated
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether improvements in behavior occur in children with phenylketonuria (PKU) who are taking Kuvan.
Details
Lead Sponsor:
Washington University School of Medicine
Collaborators:
BioMarin Pharmaceutical
Northwestern University
Oregon Health and Science University
University of Missouri-Columbia